scholarly article | Q13442814 |
P50 | author | Barry E Storer | Q75025396 |
Vernon K Sondak | Q100288223 | ||
P2093 | author name string | Jayasri G Iyer | |
Paul Nghiem | |||
Jeffrey E Gershenwald | |||
Shailender Bhatia | |||
Arthur J Sober | |||
Upendra Parvathaneni | |||
David Byrd | |||
Ata Moshiri | |||
P2860 | cites work | The role of postoperative radiation and chemoradiation in merkel cell carcinoma: a systematic review of the literature | Q21129301 |
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus | Q24645091 | ||
Clonal integration of a polyomavirus in human Merkel cell carcinoma | Q24657675 | ||
Merkel cell carcinoma: prognosis and treatment of patients from a single institution | Q28242597 | ||
Merkel cell carcinoma: changing incidence trends | Q28299460 | ||
Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases | Q33944415 | ||
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system | Q34208807 | ||
CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study. | Q34240920 | ||
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 | ||
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. | Q34866209 | ||
Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood. | Q35510910 | ||
Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies | Q35831412 | ||
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. | Q36585604 | ||
Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage | Q36605019 | ||
Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease--results from a review of 82 consecutive cases diagnosed between 1992 and 2004. | Q36759136 | ||
Adjusted estimates for time-to-event endpoints | Q37140310 | ||
The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients | Q37638853 | ||
Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer. | Q37939726 | ||
Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma | Q37954587 | ||
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma | Q38966773 | ||
Merkel cell carcinoma: more deaths but still no pathway to blame | Q40093442 | ||
Radiation monotherapy as regional treatment for lymph node-positive Merkel cell carcinoma | Q43802257 | ||
Adjuvant local irradiation for Merkel cell carcinoma | Q44367677 | ||
Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study | Q44461515 | ||
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. | Q44880020 | ||
Effect of radiation therapy on survival in patients with resected Merkel cell carcinoma: a propensity score surveillance, epidemiology, and end results database analysis | Q46520017 | ||
Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? | Q46672842 | ||
Radiotherapy alone for primary Merkel cell carcinoma | Q47319223 | ||
Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin | Q47579120 | ||
Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinoma. | Q50942549 | ||
The role of radiotherapy in the management of primary cutaneous neuroendocrine tumors (Merkel cell or trabecular carcinoma): experience at the Peter MacCallum Cancer Institute (Melbourne, Australia) | Q68414510 | ||
Radiotherapy for Merkel cell carcinoma of the skin of the head and neck | Q71741789 | ||
Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients managed with surgery alone | Q84243624 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Merkel cell carcinoma | Q1711744 |
adaptive radiation therapy | Q180507 | ||
chemotherapy | Q974135 | ||
P577 | publication date | 2016-05-31 | |
P1433 | published in | Journal of the National Cancer Institute | Q400279 |
P1476 | title | Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base | |
P478 | volume | 108 |
Q47177860 | Adjuvant radiation therapy improves patient survival in early-stage merkel cell carcinoma: A 15-year single-institution study. |
Q91854065 | Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival |
Q64932128 | Burden of Disease, Early Diagnosis, and Treatment of Merkel Cell Carcinoma in Latin America. |
Q88260935 | Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma? |
Q48161577 | Disease site as a determinant of survival outcome in patients with primary cutaneous peripheral T-cell lymphoma, unspecified: an analysis of 4057 cases from the US National Cancer Database. |
Q92067385 | Evaluation of Lymph Node Ratio Association With Long-term Patient Survival After Surgery for Node-Positive Merkel Cell Carcinoma |
Q39012295 | Factors influencing radiation treatment recommendations in early-stage Merkel cell carcinoma: a survey of US-based radiation oncologists |
Q38659987 | Identifying an Optimal Adjuvant Radiotherapy Dose for Extremity and Trunk Merkel Cell Carcinoma Following Resection: An Analysis of the National Cancer Database. |
Q55417167 | Immunotherapy for Merkel cell carcinoma: a turning point in patient care. |
Q38859191 | Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection. |
Q42370570 | Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma? |
Q89976301 | Management Recommendations for Merkel Cell Carcinoma-A Danish Perspective |
Q47321036 | Management of cutaneous Merkel cell carcinoma |
Q64982129 | Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies. |
Q89738686 | Merkel cell carcinoma |
Q50060650 | Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy |
Q40046580 | Merkel cell polyomavirus and Merkel cell carcinoma. |
Q92292072 | Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance |
Q33887689 | Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination. |
Q92953428 | Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma |
Q38915288 | Reduced H3K27me3 expression in Merkel cell polyoma virus-positive tumors |
Q51732890 | Update on Merkel Cell Carcinoma. |
Q49715996 | What's new in oncodermatology? |
Search more.